Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
With only a change of €0.20 (0.090%) the Jazz Pharmaceuticals plc price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 49 Buy predictions and no Sell predictions.
As a result the target price of 236 € shows a slightly positive potential of 6.35% compared to the current price of 221.9 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.090% | 1.232% | 2.211% | 130.665% | 53.670% | 85.690% | 73.971% |
| Repligen Corp. | 2.170% | 14.731% | 15.762% | 47.380% | 0.639% | -9.135% | -33.544% |
| Opko Health Inc. | 2.680% | -2.542% | -10.156% | 10.619% | 5.485% | -35.262% | -63.492% |
| Shanghai Fosun Pharmaceutical Group Co Ltd | 3.460% | 5.253% | 4.726% | -5.731% | -11.739% | -18.604% | -75.119% |
Comments
Jazz Pharmaceuticals (JAZZ) had its price target raised by JPMorgan Chase & Co. from $265.00 to $276.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for JAZZ provided by MarketBeat